Interferon-alpha Treatment of Hepatitis C Patients With Psychiatric Illness: Evidence-Based Risk-Benefit Assessment.
Rifai
Muhamad Aly
MA
Office of the Clinical Director, National Institute of Mental Health, Bethesda, Maryland.